Posted on April 27, 2016

World Immunization Week

The World Health Organisation’s (WHO) push to close the immunization gap encompasses many of NEHI’s core values- accelerating the adoption of valuable innovation – and has been a part of NEHI’s work (SEE NEHI’s 2009 Report Challenges in Vaccine Policy: A Case Study of the HPV Vaccine.

World Immunization Week 2016

April 24-30, 2016

 WIW Image

Immunization already saves about 2 to 3 million lives annually, but could protect an additional 1.5 million lives if global vaccination coverage were to improve. The World Health Organisation’s (WHO) push to close the immunization gap encompasses many of NEHI’s core values  - accelerating the adoption of valuable innovation – and has been a part of NEHI’s work (SEE NEHI’s 2009 Report Challenges in Vaccine Policy: A Case Study of the HPV Vaccine. And, NEHI’S membership have been integral to the advancement of vaccines to improve and save lives. Check out some of our members that advocating for and advancing progress in the immunization field:

  • Amgen:
    • Amgen has developed a vaccine that also doubles as a viral therapy. The vaccine, T-Vec, is approved to help treat adults with melanoma that have inoperable tumors.
  • EMD Serano
    • EMD Serano is researching therapeutic cancer vaccines through their innovative research program called immuno-oncology (iONC ™).
  • GSK
  • Johnson & Johnson
    • The Ebola outbreak spurred Johnson and Johnson to try to ensure that another one never occurs. The company is heavily invested in finding and promoting a vaccine
  • Merck
    • A leader in developing and manufacturing vaccines, Merck has committed to the UN Foundation and others to ensure that vaccines are used in developing nations and diseases are being eradicated.
  • National Association of Chain Drug Stores Foundation-
    • In the US, pharmacists play an important role in ensuring vaccinations reach those who need them most. As a cross-sector NEHI member, NACDS recognizes this and is promoting their membership to help improve immunization collaboration.
  • Sanofi-
    • Dengue fever affects around 390 million people worldwide each year with an estimated 3.9 billion people at risk for infection. Sanofi’s vaccination efforts to combat Dengue received a positive recommendation from the WHO.
  • Pfizer-
    • Pfizer is leader in a bacterial vaccination that can cause pneumonia, ear infections, meningitis and more in young children and adults. Pfizer is committed to bringing these vaccines and others to those living in the developing world.

If you’re interested in learning more about vaccines, join the conversation on twitter using the hashtag #vaccineswork or check out the official World Immunization Week website on the WHO’s website. 

View more news

NEHI Member Spotlight

See our full member directory

Back to Top